Benzinga | May 11, 2021 07:45AM EDT

B of A Securities Initiates Coverage On Recursion Pharmaceuticals with Buy Rating, Announces Price Target of $31

B of A Securities initiates coverage on Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy rating and announces Price Target of $31.